HK1016067A1 - Topical bisphosphonates for prevention of bone resorption - Google Patents
Topical bisphosphonates for prevention of bone resorptionInfo
- Publication number
- HK1016067A1 HK1016067A1 HK99101081A HK99101081A HK1016067A1 HK 1016067 A1 HK1016067 A1 HK 1016067A1 HK 99101081 A HK99101081 A HK 99101081A HK 99101081 A HK99101081 A HK 99101081A HK 1016067 A1 HK1016067 A1 HK 1016067A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- bisphosphonates
- bone resorption
- topical
- prevention
- bone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1163296P | 1996-02-14 | 1996-02-14 | |
GBGB9603125.7A GB9603125D0 (en) | 1996-02-15 | 1996-02-15 | Topical bisphosphonates for prevention of bone resorption |
PCT/IL1997/000050 WO1997029754A1 (en) | 1996-02-14 | 1997-02-12 | Topical bisphosphonates for prevention of bone resorption |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1016067A1 true HK1016067A1 (en) | 1999-10-29 |
Family
ID=26308705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99101081A HK1016067A1 (en) | 1996-02-14 | 1999-03-16 | Topical bisphosphonates for prevention of bone resorption |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0886521B1 (xx) |
JP (1) | JP2000504718A (xx) |
AT (1) | ATE240737T1 (xx) |
AU (1) | AU723516B2 (xx) |
CA (1) | CA2245793A1 (xx) |
DE (1) | DE69722190T2 (xx) |
ES (1) | ES2197329T3 (xx) |
HK (1) | HK1016067A1 (xx) |
WO (1) | WO1997029754A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0824341A4 (en) * | 1995-05-12 | 1999-07-07 | Merck & Co Inc | PREVENTING TOOTH LOSS THROUGH ADMINISTRATION OF ALENDRONATE OR ITS SALTS |
CN1191833C (zh) | 1999-11-25 | 2005-03-09 | 山之内制药株式会社 | 牙周病治疗药 |
US6410520B2 (en) | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
WO2002004038A1 (en) * | 2000-07-12 | 2002-01-17 | Hopital Orthopedique De La Suisse Romande | Active biocoating for bone implant |
EP2055297A1 (en) * | 2007-11-05 | 2009-05-06 | Merz Pharma GmbH & Co. KGaA | Therapy option for recoloration of hair via bisphosphonates by physiological repigmentation with age-related and/or premature "grayed" patients |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL74617A (en) * | 1985-03-15 | 1988-11-15 | Yeda Res & Dev | Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals |
US5002769A (en) * | 1987-03-13 | 1991-03-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions for the sustained-release of chlorhexidine |
US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
JP3411690B2 (ja) * | 1994-09-21 | 2003-06-03 | 帝人株式会社 | 局所投与用アレンドロン酸ナトリウム製剤 |
-
1997
- 1997-02-12 CA CA002245793A patent/CA2245793A1/en not_active Abandoned
- 1997-02-12 AT AT97902554T patent/ATE240737T1/de not_active IP Right Cessation
- 1997-02-12 EP EP97902554A patent/EP0886521B1/en not_active Expired - Lifetime
- 1997-02-12 JP JP9529156A patent/JP2000504718A/ja active Pending
- 1997-02-12 WO PCT/IL1997/000050 patent/WO1997029754A1/en active IP Right Grant
- 1997-02-12 ES ES97902554T patent/ES2197329T3/es not_active Expired - Lifetime
- 1997-02-12 DE DE69722190T patent/DE69722190T2/de not_active Expired - Fee Related
- 1997-02-12 AU AU16161/97A patent/AU723516B2/en not_active Ceased
-
1999
- 1999-03-16 HK HK99101081A patent/HK1016067A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69722190T2 (de) | 2004-05-27 |
AU723516B2 (en) | 2000-08-31 |
ATE240737T1 (de) | 2003-06-15 |
EP0886521B1 (en) | 2003-05-21 |
EP0886521A1 (en) | 1998-12-30 |
AU1616197A (en) | 1997-09-02 |
DE69722190D1 (de) | 2003-06-26 |
ES2197329T3 (es) | 2004-01-01 |
WO1997029754A1 (en) | 1997-08-21 |
JP2000504718A (ja) | 2000-04-18 |
CA2245793A1 (en) | 1997-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI110667B (fi) | Menetelmä farmaseuttisen valmisteen valmistamiseksi | |
NZ272608A (en) | Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts | |
HUP9801615A3 (en) | Simethicone/anhydrous calcium phosphate compositions | |
CA2332959A1 (en) | The use of an anti-microbial compound for disinfection | |
BR9912659A (pt) | Composição tópica antiperspirante, processo de redução da pespiração de pele humana, e, processo de aumento da eficácia antiperspirante de uma composição antiperspirante anidra | |
MX9704776A (es) | Formulaciones que reducen irritacion de la piel y uso de las mismas. | |
HK1004663A1 (en) | Formulations and methods for reducing skin irritation | |
CA2172493A1 (en) | Use of angiotensin iii and analogs thereof in tissue repair | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
MX9703609A (es) | Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido. | |
AU7449598A (en) | Medicinal composition for prevention or treatment of hepatopathy | |
RU93054017A (ru) | Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза | |
ZA941525B (en) | Use of riluzole in the treatment of nero-AIDS | |
AU1653595A (en) | Pharmaceutical composition for treating osteoporosis | |
NO944501D0 (no) | Tiosubstituerte nitrogenholdige heterocykliske fosfonatforbindelser for å behandle unormal kalsium- og fosfatmetabolisme | |
CA2200651A1 (en) | Sodium alendronate preparation for local administration | |
HK1016067A1 (en) | Topical bisphosphonates for prevention of bone resorption | |
CA2198580A1 (en) | Combination therapy to treat osteoporosis | |
NO944500D0 (no) | Tiosubstituerte cykliske fosfonatforbindelser for å behandle unormal kalsium- og fosfatmetabolisme | |
WO1996028151A3 (en) | Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs | |
PL328198A1 (en) | Antiasthmatic therapeutic agents containing organic selenium compounds | |
SG66248A1 (en) | External skin treatment agent composition containing prostacyclins as active ingredient | |
BR0016646A (pt) | Método para tratar um paciente que sofre de dor, e, composição farmacêutica | |
AU1067795A (en) | Use of lithium compounds in the treatment and prevention of alzheimer's disease | |
WO1999050252A3 (en) | Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20070212 |